The related mechanism of radiotherapy in triple-negative breast cancer

doi:10.3969/j.issn.1007-3969.2014.11.012

China Oncology ›› 2014, Vol. 24 ›› Issue (11): 865-870.doi: 10.3969/j.issn.1007-3969.2014.11.012

Previous Articles Next Articles

The related mechanism of radiotherapy in triple-negative breast cancer

LI Bing-xin¹, FU Shen²

1.Department of Radiation Oncology, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai 200032, China; 2. Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Shanghai 201321, China

Online:2014-11-30 Published:2015-05-05
Contact: FU Shen E-mail: shen_fu@hotmail.com

Abstract

Abstract: Radiotherapy is one of the main means of local treatment of breast cancer. Triple negative breast cancer (TNBC) as a molecular subtypes of breast cancer, its biological behavior is special and existing multiple molecular targets, these molecular targets influence the response of ionization radiation through different mechanisms and regulate radiotherapy sensitivity of TNBC This article reviewed the recent advances in radiotherapy and radiosensitivity related molecular targets of TNBC.

Key words: Triple-negative breast cancer, Radiotherapy, Radiosensitivity, Biomarker

LI Bing-xin, FU Shen. The related mechanism of radiotherapy in triple-negative breast cancer[J]. China Oncology, 2014, 24(11): 865-870.

[1]	YANG Yanju, ZHONG Yang, HU Weigang, GAO Dadi, ZHAO Jun. Effects of CT-RED calibration curves of different simulators on dose distribution of tumor target and organs at risk [J]. China Oncology, 2021, 31(9): 828-837.
[2]	XIE Mengqing, CHU Xiangling, ZHOU Juan, SU Chunxia. The advances in immunotherapy biomarkers of small cell lung cancer [J]. China Oncology, 2021, 31(7): 635-639.
[3]	YIN Zhihai, WANG Juanqi, MENG Yiran, XU Qing, YANG Zhaozhi. Investigation of patient characteristics associated with setup errors in intensity-modulated radiotherapy after breast-conserving surgery [J]. China Oncology, 2021, 31(3): 198-202.
[4]	HU Xi’e , YANG Zhenyu , XUE Jingyi , YANG Ping , PENG Shujia , YUAN Lijuan , BAO Guoqiang . Research progress of single-cell sequencing in neoadjuvant chemotherapy for triple-negative breast cancer [J]. China Oncology, 2021, 31(3): 221-226.
[5]	LU Dasong, FENG Yongjun, WANG Wufeng, MOU Zhonglin, ZHAO Na . Influence of individualized nutrition intervention on quality of life and survival prognosis of patients with locally advanced nasopharyngeal carcinoma [J]. China Oncology, 2021, 31(12): 1202-1208.
[6]	The Society of Gynecological Cancer of China Anti-Cancer Association, Chinese Society of Pathology of the Chinese Medical Association, National Pathology Quality Control Center. The Chinese Expert Consensus Recommendations on Molecular Testing in Endometrial Cancer (2021 edition) [J]. China Oncology, 2021, 31(11): 1126-1144.
[7]	CHEN Gang, ZHANG Shunkang, SHEN Lei, SUN Liyun, ZHAO Yingwei, WANG Xin, WANG Huanhuan, LU Yue. Comparison of three types of intensity-modulated radiotherapy plans for adjuvant whole breast and simultaneous tumor bed boost radiotherapy [J]. China Oncology, 2020, 30(8): 611-619.
[8]	ZHANG Xiaomeng , MA Ningyi , ZHU Hongcheng , AI Dashan , REN Zhigang . Efficacy and prognostic factors of adjuvant radiotherapy combined with chemotherapy in patients with pancreatic cancer [J]. China Oncology, 2020, 30(7): 519-524.
[9]	WU Jingwen, YU Xuejuan, YANG Qiu’an. Association between Onodera’s prognostic nutrition index and adverse effects of concurrent chemoradiotherapy for esophageal squamous cell carcinoma [J]. China Oncology, 2020, 30(7): 525-530.
[10]	JIANG Mengyi , LU Yanqiao , WANG Hongxia . Research progress and clinical significance of breast cancer heterogeneity [J]. China Oncology, 2020, 30(5): 394-400.
[11]	SHI Zhiqiang , QIU Pengfei , LIU Yanbing , ZHAO Tong , SUN Xiao , CHEN Peng , WANG Chunjian , ZHANG Zhaopeng , CONG Binbin , WANG Yongsheng . Selective elimination of axillary surgery staging after neoadjuvant chemotherapy for HER2 positive and triple-negative breast cancer [J]. China Oncology, 2020, 30(3): 186-191.
[12]	DING Lin , YUAN Hang , ZHAO Xiaohui , GUAN Xuedan , JIANG Yanhui , LIU Yimin , BI Zhuofei . Sarcomatoid carcinoma of oral cavity: a case report [J]. China Oncology, 2020, 30(3): 237-240.
[13]	XU Wencai, GUO Leiming, CUI Yingying, LIU Xiao, JIANG Yue, GE Hong. The effect of lung stereotactic body radiotherapy on peripheral blood lymphocytes [J]. China Oncology, 2020, 30(12): 1013-1016.
[14]	WANG Jie . Challenges and directions of immune checkpoint inhibitors in the treatment of lung cancer [J]. China Oncology, 2020, 30(10): 744-749.
[15]	XU Xinyan , CHEN Jiayan , MAO Jingfang , FAN Min . Radiotherapy for non-small cell lung cancer: evolution and development [J]. China Oncology, 2020, 30(10): 777-784.

The related mechanism of radiotherapy in triple-negative breast cancer

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments